CLINICAL_TRIALS
research
· 2016-04-27
Clinical Trial Update: Nalmefene in Alcohol Dependence and Borderline Personality Disorder [NA]
Summary
Nalmefene is being studied for Alcohol Use Disorder and Borderline Personality Disorder, with the trial status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Alcohol Use Disorder, Borderline Personality Disorder | NA | Status: UNKNOWN